Skip to main content
Evome Medical Technologies Inc. (LNDZF)
OTCMKTS · Delayed Price · Currency is USD
0.0040
-0.0410 (-91.11%)
At close: Apr 22, 2025

LNDZF Revenue

Evome Medical Technologies had revenue of 9.51M CAD in the quarter ending September 30, 2024, a decrease of -49.95%. This brings the company's revenue in the last twelve months to 45.36M, down -19.17% year-over-year. In the year 2023, Evome Medical Technologies had annual revenue of 59.99M with 51.46% growth.

Revenue (ttm)
45.36M CAD
Revenue Growth
-19.17%
P/S Ratio
0.01
Revenue / Employee
221.27K CAD
Employees
205
Market Cap
300.16K USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202359.99M20.38M51.46%
Dec 31, 202239.61M21.68M120.96%
Feb 28, 202217.92M17.96M-53,530.12%
Feb 28, 2021-33.55K-367.92K-110.03%
Feb 29, 2020334.37K-865.55K-72.13%
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro
Feb 28, 2017 Pro Pro Pro
Feb 29, 2016 Pro Pro Pro
Feb 28, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 215.62M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
Silence Therapeutics 27.70M
Revenue Rankings

Evome Medical Technologies News

More News